Rationale for Extended Adjuvant Letrozole after Five Years of Tamoxifen in Postmenopausal Oestrogen Receptor–Positive Women with Early-Stage Breast Cancer

Hormonal therapy has been an integral component of the adjuvant strategy for women with hormone receptor–positive breast cancer for decades [...]